Ipsen
Ipsen SA engages in the research, development, manufacture, and sale of pharmaceutical products worldwide.
Launch date
Employees
Market cap
AUD14.8b
Enterprise valuation
AUD14.4b (Public information from Sep 2024)
Share price
€109 IPN.PA
Boulogne-Billancourt Île-de-France (HQ)
No columns specified